We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Complementary Bonds: Strategic Collaboration Between ELRIG and BPS Announced at Pharmacology 2019

Article   Dec 20, 2019 | by Ruairi J Mackenzie, Science Writer for Technology Networks

 
Complementary Bonds: Strategic Collaboration Between ELRIG and BPS Announced at Pharmacology 2019
 
 
 

RELATED ARTICLES

Meet the Culprits of Cell Culture Contamination

Article

Cell culture contamination is a problem on many levels, creating immediate implications for experiments and wider issues for the scientific community.

READ MORE

Nanoparticle Drug Delivery Could Offer More Effective Pain Relief Than Opioids

Article

Historically, efforts to target the substance P (SP) neurokinin 1 receptor (NK1R), for the treatment of pain have failed. These studies had one critical flaw, whilst they were targeting the right receptor, they were focusing on the wrong location.

READ MORE

Exploring the Medicinal Benefits of Cannabis Within UK Pharmaceuticals

Article

In this article, we explore how the use of cannabis within UK pharmaceuticals is expected to change, as well as the medicinal benefits offered by cannabis, and cannabinoids.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE